ResMed Valuation
RME Stock | EUR 236.00 0.50 0.21% |
At this time, the company appears to be fairly valued. ResMed Inc holds a recent Real Value of 230.03 per share. The prevailing price of the company is 236.0. Our model determines the value of ResMed Inc from analyzing the company fundamentals such as Return On Equity of 0.24, shares outstanding of 146.91 M, and Operating Margin of 0.28 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that ResMed's price fluctuation is very steady at this time. Calculation of the real value of ResMed Inc is based on 3 months time horizon. Increasing ResMed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ResMed stock is determined by what a typical buyer is willing to pay for full or partial control of ResMed Inc. Since ResMed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ResMed Stock. However, ResMed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 236.0 | Real 230.03 | Hype 236.0 | Naive 244.21 |
The real value of ResMed Stock, also known as its intrinsic value, is the underlying worth of ResMed Inc Company, which is reflected in its stock price. It is based on ResMed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ResMed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ResMed Inc helps investors to forecast how ResMed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ResMed more accurately as focusing exclusively on ResMed's fundamentals will not take into account other important factors: ResMed Total Value Analysis
ResMed Inc is at this time estimated to have takeover price of 31.17 B with market capitalization of 29.28 B, debt of 765.33 M, and cash on hands of 147.13 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ResMed fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
31.17 B | 29.28 B | 765.33 M | 147.13 M |
ResMed Investor Information
About 67.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.74. ResMed Inc recorded earning per share (EPS) of 5.17. The entity last dividend was issued on the 8th of February 2023. The firm had 2:1 split on the 31st of August 2010. Based on the measurements of operating efficiency obtained from ResMed's historical financial statements, ResMed Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.ResMed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ResMed has an asset utilization ratio of 70.22 percent. This implies that the Company is making 0.7 for each dollar of assets. An increasing asset utilization means that ResMed Inc is more efficient with each dollar of assets it utilizes for everyday operations.ResMed Ownership Allocation
ResMed owns a total of 146.91 Million outstanding shares. Over half of ResMed's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in ResMed. Please watch out for any change in the institutional holdings of ResMed Inc as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.ResMed Profitability Analysis
The company reported the revenue of 3.58 B. Net Income was 779.44 M with profit before overhead, payroll, taxes, and interest of 2.06 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ResMed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ResMed and how it compares across the competition.
About ResMed Valuation
The stock valuation mechanism determines ResMed's current worth on a weekly basis. Our valuation model uses a comparative analysis of ResMed. We calculate exposure to ResMed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ResMed's related companies.ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. RESMED INC is traded on Frankfurt Stock Exchange in Germany.
8 Steps to conduct ResMed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ResMed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ResMed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ResMed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ResMed's revenue streams: Identify ResMed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ResMed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ResMed's growth potential: Evaluate ResMed's management, business model, and growth potential.
- Determine ResMed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ResMed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |